Quick Answer
Biomea Fusion, Inc. reported Net Income Loss of -$61.80 million for the year ending 2025.
- Biomea Fusion, Inc. showed an increase of +55.4% in Net Income Loss from 2024 to 2025.
- This data is from Biomea Fusion, Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: -$398.0 thousand | Q2 2020: -$293.0 thousand | Q3 2020: -$1.14 million | Q4 2020: -$3.50 million | Q1 2021: -$5.85 million | Q2 2021: -$8.40 million | Q3 2021: -$12.61 million | Q4 2021: -$14.71 million | Q1 2022: -$16.37 million | Q2 2022: -$17.26 million | Q3 2022: -$22.89 million | Q4 2022: -$25.31 million | Q1 2023: -$29.05 million | Q2 2023: -$24.89 million | Q3 2023: -$28.43 million | Q4 2023: -$34.88 million | Q1 2024: -$39.06 million | Q2 2024: -$37.28 million | Q3 2024: -$32.79 million | Q4 2024: -$29.30 million | Q1 2025: -$29.26 million | Q2 2025: -$20.74 million | Q3 2025: -$16.41 million.
- Over the full 7 years of available data (2019 to 2025), Biomea Fusion, Inc.'s Net Income Loss has declined by 5,058.3%.
- Historical annual values: Fiscal year 2025: -$61.80 million | Fiscal year 2024: -$138.43 million | Fiscal year 2023: -$117.26 million | Fiscal year 2022: -$81.83 million | Fiscal year 2021: -$41.57 million | Fiscal year 2020: -$5.32 million | Fiscal year 2019: -$1.20 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: